Resident Th1-like effector memory cells in pulmonary recall responses to Mycobacterium tuberculosis

American Journal of Respiratory Cell and Molecular Biology

Volumn 33, Issue 1, 2005, Pages 48-55

  Walrath, Jessica ^b   Zukowski, Lynn ^b   Krywiak, Adriana ^b   Silver, Richard F ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Chemokines; Recall responses; Resident memory cells; Tuberculosis

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOKINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG LAVAGE; MALE; MEMORY CELL; MYCOBACTERIUM TUBERCULOSIS; RECALL; TH1 CELL;

ADOLESCENT; ADULT; ANTIGENS, CD45; BRONCHOALVEOLAR LAVAGE; BRONCHOSCOPY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL MEMBRANE; CHEMOKINES; CHEMOKINES, CXC; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; LIGANDS; LUNG; LYMPHOCYTE SUBSETS; LYMPHOCYTES; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; RANTES; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; TH1 CELLS; TUBERCULIN;

MYCOBACTERIUM TUBERCULOSIS;

EID: 21844436875     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2005-0060OC     Document Type: Article

References (29)

1. Schluger N, Rom WN. The host immune response to tuberculosis. Am J Respir Crit Care Med 1998;157:679-691.
2. Stead W. Management of health care workers after inadvertent exposure to tuberculosis: a guide for the use of preventative therapy. Ann Intern Med 1995;122:906-912.
3. Calhoun W, Jarjour NN, Gleich GJ, Stevens CA, Busse WW. Increased airway inflammation with segmental versus aerosol antigen challenge. Am Rev Respir Dis 1993;147:1465-1471.
4. Jarjour N, Peters SP, Djukanovic R, Calhoun WJ. Investigative use of bronchoscopy in asthma. Am J Respir Crit Care Med 1998;157:692-697.
5. Metzger W, Richerson HB, Worden K, Monick M, Hunninghake GW. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs: description of the model and local airway inflammation. Am Rev Respir Dis 1987;135:433-440.
6. Silver R, Zukowski L, Kotake S, Li Q, Pozuelo F, Krywiak A, Larkin R. Recruitment of antigen-specific Th1-like responses to the human lung following bronchscopic segmental challenge with purified protein derivative of Mycobacterium tuberculosis. Am J Respir Cell Mol Biol 2003;29:117-123.
7. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, Koch AE, Moser B, Mackay CR. The chemokine receptors CXCR3 and CCR5 mark subsets of T-cells associated with certain inflammatory reactions. J Clin Invest 1998;101:746-754.
8. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999;401:708-712.
9. Ravn P, Boesen H, Pedersen BK, Andersen P. Human T cell responses induced by vaccination with Mycobacterium bovis bacillus Calmette-Guerin. J Immunol 1997;158:1949-1955.
10. Hoft D, Brown R, Roodman S. A double-blind, placebo-controlled study of mycobacterium-specific human immune responses induced by intradermal bacille Calmette-Guerin vaccination. J Lab Clin Med 1999;134:244-252.
11. Hoft D, Worku S, Kampmann B, Whalen CC, Ellner JJ, Hirsch CS, Brown RB, Larkin R, Ling Q, Yun H, et al. Investigation of the relationship between immune-mediated inhibition of myocbacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity. J Infect Dis 2002;186:1448-1457.
12. Silver R, Wallis RS, Ellner JJ. Mapping of T cell epitopes of the 30-kD a antigen of Mycobacterium bovis strain Bacillus Calmette Guerin in purified protein derivative (PPD) positive individuals. J Immunol 1995;154:4665-4674.
13. Schwander S, Torres M, Sada E, Carranza C, Ramos E, Tary-Lehmann M, Wallis RS, Sierra J, Rich EA. Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis. J Infect Dis 1998;178:1434-1445.
14. Schwander SK, Torres M, Carranza C, Escobedo D, Tary-Lehmann M, Anderson P, Toossi Z, Ellner JJ, Rich EA, Sada E. Pulmonary mono-nuclear cell responses to antigens of Mycobacterium tuberculosis in healthy household contacts of patients with active tuberculosis and healthy controls from the community. J Immunol 2000;165:1479-1485.
15. Hogan R, Usherwood EJ, Zhong W, Roberts AD, Dutton RW, Harmsen AG, Woodland DL. Activated antigen-specific CD8+ T-cells persist in the lungs following recovery from respiratory virus infections. J Immunol 2001;166:1813-1822.
16. Hogan R, Zhong W, Usherwood EJ, Cookenham T, Roberts AD, Woodland DL. Protection from respiratory virus infections can be mediated by antigen-specific CD4+ T cells that persist in the lungs. J Exp Med 2001;193:981-986.
17. Foutenot A, Cavanera SJ, Gharavi L, Newman LS, Kotzin BL. Target organ localization of memory CD4+ T-cells in patients with chronic beryllium disease. J Clin Invest 2002;110:1473-1482.
18. Manabe Y, Bishai WR. Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting. Nat Med 2000;6:1327-1329.
19. Flynn J, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon γ in resistance of Mycobacterium tuberculosis infection. J Exp Med 1993;128:2249-2254.
20. Dorman SE, Holland SM. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest 1998;101:2364-2369.
21. Elloumia-Zghal H, Barbouche MR, Chemli J, Bejaoui M, Harbi A, Snoussi N, Abdelhak S, Dellagi K. Clinical and genetic heterogeneity of inherited autosomal recessive susceptibility to disseminated Mycobacterium bovis bacille calmette-guerin infection. J Infect Dis 2002;185:1468-1475.
22. Douvas GS, Crowle AJ. γ-Inteferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infect Immun 1985;51:1-8.
23. Rook GAW, Steele J, Ainsworth M, Champion BR. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant γ-interferon on human monocytes and murine peritoneal macrophages. Immunology 1986;59:333-338.
24. Silver RF, Li Q, Boom WH, Ellner JJ. Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes: requirement for CD4+ T-cells in purified-protein derivative-positivie subjects, but not in purified protein derivative-negative subjects. J Immunol 1998;160:2408-2417.
25. Condos R, Rom WN, Schluger NW. Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol. Lancet 1997;349:1513-1515.
26. Raju B, Hoshino Y, Kuwabara K, Belitskaya I, Prabhakar S, Canova A, Gold JA, Condos R, Pine RI, Brown S, et al. Aerozolized gamma interferon (IFN-γ) induced expression of the genes encoding the IFN-γ-inducible 10 kilodalton protein but not inducible nitric oxide synthase in the lung during tuberculosis. Infect Immun 2004;72:1275-1283.
27. Souto J, Aliberti JC, Campanelli AP, Livonesi MC, Maffei LML, Ferreira BR, Travassos LR, Martinez R, Rossi MA, Silva JS. Chemokine production and leukocyte recruitment to the lungs of Paracoccidioides brasiliensis-iniected mice is modulated by Interferon γ. Am J Pathol 2003;163:583-590.
28. Sauty A, Dziejman M, Taha RA, Iarossi AS, Neote K, Garcia-Zepeda EA, Hamid Q, Luster AD. The T-cell specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J Immunol 1999;162:3549-3558.
29. Palendira U, Bean AGD, Feng CG, Britton WJ. Lymphocyte recruitment and protective efficacy against pulmonary mycobacterial infection are independent of the route of prior Mycobacterium bovis BCG immunization. Infect Immun 2002;70:1410-1416.